InnospecIOSP +1.63%76 9-Day RSI is 46.28 as of Jul. 02, 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.73 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,654 Chemicals companies, Innospec ranks better than 53.2% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-02), Innospec's 9-Day RSI is 46.28.
The industry rank for Innospec's 9-Day RSI or its related term are showing as below:
IOSP's 9-Day RSI is ranked better than 53.2% of 1654
companies
in the Chemicals industry
Industry Median: 47.29
vs IOSP: 46.28
Innospec (NAS:IOSP) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Innospec 9-Day RSI Related Terms
IOSP vs MTX, ODC, NGVT: 9-Day RSI Comparison
For the Specialty Chemicals subindustry, Innospec's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innospec 9-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Innospec's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Innospec's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innospec (IOSP) has a 9-Day RSI of 46.28 as of Jul. 02, 2026. According to the industry distribution chart, Innospec ranks #774 out of 1654 companies in the Chemicals industry, placing it in the top 46.8%.
Is Innospec's 9-Day RSI too high?
Innospec's current 9-Day RSI is 46.28. The Chemicals industry median 9-Day RSI is 47.29. Innospec's value of 46.28 is 2.1% below this industry median. Based on the distribution chart, Innospec ranks #774 out of 1654 companies in the Chemicals industry, which is above the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's 9-Day RSI compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #774 out of 1654 companies for 9-Day RSI. This puts Innospec in the upper half of its industry. The industry median 9-Day RSI is 47.29. Innospec's value of 46.28 is 2.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Chemicals company?
The median 9-Day RSI among Chemicals companies is 47.29, based on 1,654 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innospec's current 9-Day RSI of 46.28 is 2.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median 9-Day RSI is 47.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current 9-Day RSI is 46.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.73, compared to a current price of $83.10 — trading 12.3% below its estimated fair value. The current 9-Day RSI is 46.28 and 2.1% below the Chemicals industry median of 47.29. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Innospec (IOSP), the current 9-Day RSI is 46.28 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innospec (IOSP) Overvalued in 2026?
Based on GuruFocus' analysis, Innospec stock appears to be undervalued.
The current stock price of $83.10 is trading 12.3% below its estimated GF Value™ of $94.73.
GuruFocus considers Innospec to be Modestly Undervalued.
Key valuation signals for IOSP:
9-Day RSI: 46.28
GF Value™: $94.73 vs. price of $83.10 (12.3% below fair value)
Industry Position: 2.1% below the Chemicals median (#774 of 1654)
No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score
Get the complete analysis for IOSP
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOSP has been successfully added to your 